4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-23-006511
EVP R&D, Chief Medical Officer gave up 16,015 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 22,195 shares (grant or award)
- EVP R&D, Chief Medical Officer acquired 25,692 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-18 | Exercise or conversion : show line 1 in the form | +8,722 | 26,716 | D | ||
| 2023-02-18 | Shares withheld for taxes : show line 2 in the form | −2,656 | $28.07 | $74,554 | 24,060 | D |
| 2023-02-20 | Exercise or conversion : show line 3 in the form | +10,095 | 34,155 | D | ||
| 2023-02-20 | Shares withheld for taxes : show line 4 in the form | −3,780 | $28.07 | $106,105 | 30,375 | D |
| 2023-02-20 | Grant or award : show line 5 in the form | +22,195 | 52,570 | D | ||
| 2023-02-20 | Shares withheld for taxes : show line 6 in the form | −6,526 | $28.07 | $183,185 | 46,044 | D |
| 2023-02-21 | Exercise or conversion : show line 7 in the form | +6,875 | 52,919 | D | ||
| 2023-02-21 | Shares withheld for taxes : show line 8 in the form | −3,053 | $27.77 | $84,782 | 49,866 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-18 | Exercise or conversion : show line 9 in the form Restricted Stock Unit Award | −8,722 | 26,167 | D |
| 2023-02-20 | Exercise or conversion : show line 10 in the form Restricted Stock Unit Award | −10,095 | 10,096 | D |
| 2023-02-21 | Exercise or conversion : show line 11 in the form Restricted Stock Unit Award | −6,875 | 0 | D |
Loading xslF345X03/form4.xml…